Aims and scope
Clinical and Translational Medicine aims to play an important and recognized role in reporting knowledge that contributes towards the understanding of molecular mechanisms of disease. The journal also aims to foster a predictive, preventive, personalized and practical approach towards precision medicine, leading to improved patient prognosis. The journal provides a forum for the exchange of ideas between basic and clinical scientists on molecular and cellular mechanisms of disease and potential therapies.
The journal covers all areas of clinical and translational medicine but also has several specialized sections:
- Clinical and translational cardiovascular medicine - Edited by Yong-Xiao Wang
- Clinical genomics - Edited by Olaf A. Bodamer and Gilbert S. Omenn
- Stem cell therapies - Edited by Mariusz Z. Ratajczak
- Translational respiratory medicine - Edited by Chunxue Bai
- Vaccination and immunotherapy – Edited by Marek Malecki
Clinical and Translational Medicine is a truly international, peer-reviewed, and open access journal devoted to the publication of articles on scientific and clinical investigations which will promote and accelerate the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal will specially focus on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from companies, clinicians, scientists and policy makers.
All articles published by Clinical and Translational Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Clinical and Translational Medicine you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the SpringerOpen copyright and license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, SpringerOpen can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Clinical and Translational Medicine therefore levies an article-processing charge of £1210.00/$1890.00/€1540.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
SpringerOpen provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Clinical and Translational Medicine are included in:
- Google Scholar
- PubMed Central
- Summon by Serial Solutions
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by SpringerOpen on SpringerLink.
We are working closely with relevant indexing services including Web of Science (Clarivate Analytics) to ensure that articles published in Clinical and Translational Medicine will be available in their databases when appropriate.
Peer review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help Editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Clinical and Translational Medicine operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two to more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. Reviewers will also be asked to indicate how interesting and significant the research is. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
All manuscripts submitted to Clinical and Translational Medicine should adhere to SpringerOpen's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Clinical and Translational Medicine
Articles in Clinical and Translational Medicine should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Clin Transl Med [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Clin Transl Med 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure.
Why publish your article in Clinical and Translational Medicine?
Clinical and Translational Medicine's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Clinical and Translational Medicine offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Clinical and Translational Medicine and SpringerOpen.
Online publication in Clinical and Translational Medicine gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Clinical and Translational Medicine are included in article alerts and regular email updates.
In addition, articles published in Clinical and Translational Medicine may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Clinical and Translational Medicine.
Authors of articles published in Clinical and Translational Medicine retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the copyright and license agreement).
For further information about the advantages of publishing in a journal from SpringerOpen, please click here.
Clinical and Translational Medicine is affiliated with the International Society for Translational Medicine.
2017 Journal Metrics
35 days from submission to first decision
74 days from submission to acceptance
15 days from acceptance to publication
174 Altmetrics mentions
- ISSN: 2001-1326